Most participants (84.9%) had AHD defined by a CD4 count of <200 cells/mm3, while the remainder had a WHO stage 3 condition or a CD4 percentage below 14%. The gene discussed is CD4; the disease is mitochondrial DNA depletion syndrome 4a.